CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $714,000 | -73.9% | 599,479 | -60.6% | 0.00% | – |
| Q2 2022 | $2,737,000 | +7.0% | 1,520,022 | +20.1% | 0.00% | – |
| Q1 2022 | $2,558,000 | +61.7% | 1,266,014 | +116.9% | 0.00% | – |
| Q4 2021 | $1,582,000 | -54.7% | 583,743 | -25.4% | 0.00% | – |
| Q3 2021 | $3,489,000 | -51.2% | 782,303 | -36.5% | 0.00% | -100.0% |
| Q2 2021 | $7,144,000 | -26.9% | 1,231,730 | -11.5% | 0.00% | 0.0% |
| Q1 2021 | $9,774,000 | -16.3% | 1,392,383 | -42.8% | 0.00% | 0.0% |
| Q4 2020 | $11,678,000 | -12.6% | 2,432,935 | +6.1% | 0.00% | -50.0% |
| Q3 2020 | $13,366,000 | -7.4% | 2,292,616 | +7.2% | 0.00% | -33.3% |
| Q2 2020 | $14,429,000 | +287.1% | 2,137,719 | +264.8% | 0.01% | +200.0% |
| Q1 2020 | $3,727,000 | -56.0% | 586,000 | -27.8% | 0.00% | -50.0% |
| Q4 2019 | $8,467,000 | +66.4% | 812,154 | -37.3% | 0.00% | +100.0% |
| Q3 2019 | $5,088,000 | -77.7% | 1,294,666 | -15.7% | 0.00% | -81.8% |
| Q2 2019 | $22,840,000 | +0.7% | 1,535,960 | +68.1% | 0.01% | 0.0% |
| Q1 2019 | $22,684,000 | +29.0% | 913,970 | -6.6% | 0.01% | +10.0% |
| Q4 2018 | $17,583,000 | -64.1% | 979,032 | -41.3% | 0.01% | -54.5% |
| Q3 2018 | $48,968,000 | -6.3% | 1,667,278 | +45.1% | 0.02% | -15.4% |
| Q2 2018 | $52,260,000 | -20.0% | 1,149,329 | -7.1% | 0.03% | -25.7% |
| Q1 2018 | $65,324,000 | +254.0% | 1,237,209 | +355.9% | 0.04% | +218.2% |
| Q4 2017 | $18,455,000 | -85.3% | 271,403 | -82.1% | 0.01% | -88.7% |
| Q3 2017 | $125,152,000 | +36.7% | 1,518,828 | +55.3% | 0.10% | +24.4% |
| Q2 2017 | $91,581,000 | +240.7% | 978,117 | +131.7% | 0.08% | +225.0% |
| Q1 2017 | $26,882,000 | +132.0% | 422,190 | +61.9% | 0.02% | +100.0% |
| Q4 2016 | $11,586,000 | -57.0% | 260,843 | -65.1% | 0.01% | -55.6% |
| Q3 2016 | $26,914,000 | +5219.0% | 746,584 | +5059.5% | 0.03% | +2600.0% |
| Q4 2015 | $506,000 | -99.1% | 14,470 | -97.7% | 0.00% | -98.2% |
| Q3 2015 | $58,113,000 | +37.0% | 631,943 | +30.9% | 0.06% | +48.6% |
| Q2 2015 | $42,416,000 | +210.9% | 482,661 | +162.6% | 0.04% | +184.6% |
| Q1 2015 | $13,643,000 | +114.6% | 183,797 | +61.9% | 0.01% | +116.7% |
| Q4 2014 | $6,356,000 | -31.7% | 113,496 | -44.7% | 0.01% | -40.0% |
| Q3 2014 | $9,302,000 | +2152.3% | 205,063 | +1951.9% | 0.01% | – |
| Q2 2014 | $413,000 | -63.8% | 9,994 | -39.4% | 0.00% | -100.0% |
| Q1 2014 | $1,141,000 | +337.2% | 16,481 | +280.4% | 0.00% | – |
| Q4 2013 | $261,000 | -92.5% | 4,332 | -91.6% | 0.00% | -100.0% |
| Q2 2013 | $3,466,000 | – | 51,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |